George E. Tranter PhD MA BSc FRSC CChem CSci, has held senior R&D positions in both industry and academia (including at London University, Oxford University, the Wellcome Foundation and GlaxoWellcome). Until 2006 he led the Biospectroscopy Centre of Imperial College London and subsequently was Senior Research Fellow of the Department of Chemistry, University of Oxford. He is a recognized international authority in the field of molecular chirality and the spectroscopic/physicochemical features of drugs and biopharmaceuticals. He is named as inventor on drug patents, has published widely in the scientific literature, co-edited The Encyclopedia of Spectroscopy & Spectrometry (Academic Press), editor of the Separations and Analysis volume of Comprehensive Chirality (Elsevier), has been a member of scientific journal editorial boards (inc. CHIRALITY) and appeared on radio and television programmes in the UK and abroad. He is also a member of various scientific advisory panels and is a key partner in collaborations that bring together the biopharmaceutical industry, academia, and governmental institutions to investigate and validate biopharmaceutical structure and function. His particular interests are in the rational discovery of new therapeutics, with a passion for the role chirality plays in nature, from the molecular level through to macroscopic structures (e.g., helical shells) and beyond.istics of marine creatures.